JP2025087764A5 - - Google Patents
Info
- Publication number
- JP2025087764A5 JP2025087764A5 JP2025031035A JP2025031035A JP2025087764A5 JP 2025087764 A5 JP2025087764 A5 JP 2025087764A5 JP 2025031035 A JP2025031035 A JP 2025031035A JP 2025031035 A JP2025031035 A JP 2025031035A JP 2025087764 A5 JP2025087764 A5 JP 2025087764A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- antibody
- complementarity determining
- determining regions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762475173P | 2017-03-22 | 2017-03-22 | |
| US62/475,173 | 2017-03-22 | ||
| EP17306079 | 2017-08-18 | ||
| EP17306079.9 | 2017-08-18 | ||
| JP2019552040A JP2020514386A (ja) | 2017-03-22 | 2018-03-22 | ヒト化抗ｃｘｃｒ５抗体を使用するループスの処置 |
| PCT/EP2018/057310 WO2018172465A1 (en) | 2017-03-22 | 2018-03-22 | Treatment of lupus using humanized anti-cxcr5 antibodies |
| JP2023003470A JP2023040241A (ja) | 2017-03-22 | 2023-01-13 | ヒト化抗ｃｘｃｒ５抗体を使用するループスの処置 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023003470A Division JP2023040241A (ja) | 2017-03-22 | 2023-01-13 | ヒト化抗ｃｘｃｒ５抗体を使用するループスの処置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025087764A JP2025087764A (ja) | 2025-06-10 |
| JP2025087764A5 true JP2025087764A5 (https=) | 2025-10-21 |
Family
ID=61827719
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019552040A Pending JP2020514386A (ja) | 2017-03-22 | 2018-03-22 | ヒト化抗ｃｘｃｒ５抗体を使用するループスの処置 |
| JP2023003470A Pending JP2023040241A (ja) | 2017-03-22 | 2023-01-13 | ヒト化抗ｃｘｃｒ５抗体を使用するループスの処置 |
| JP2025031035A Pending JP2025087764A (ja) | 2017-03-22 | 2025-02-28 | ヒト化抗ｃｘｃｒ５抗体を使用するループスの処置 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019552040A Pending JP2020514386A (ja) | 2017-03-22 | 2018-03-22 | ヒト化抗ｃｘｃｒ５抗体を使用するループスの処置 |
| JP2023003470A Pending JP2023040241A (ja) | 2017-03-22 | 2023-01-13 | ヒト化抗ｃｘｃｒ５抗体を使用するループスの処置 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240207397A1 (https=) |
| EP (1) | EP3601344A1 (https=) |
| JP (3) | JP2020514386A (https=) |
| KR (2) | KR20190131068A (https=) |
| CN (1) | CN110662767A (https=) |
| AU (1) | AU2018238540B2 (https=) |
| IL (2) | IL318907A (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023010483A1 (en) * | 2021-08-05 | 2023-02-09 | Hifibio (Hk) Limited | Anti-human cxcr5 antibody and uses thereof |
| WO2021216505A1 (en) * | 2020-04-21 | 2021-10-28 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized cxcl13 gene |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111909273B (zh) * | 2007-08-29 | 2024-03-26 | 塞诺菲-安万特股份有限公司 | 人源化的抗-cxcr5抗体、其衍生物及它们的应用 |
| WO2012010582A1 (en) * | 2010-07-21 | 2012-01-26 | Roche Glycart Ag | Anti-cxcr5 antibodies and methods of use |
| AU2015305850A1 (en) * | 2014-08-22 | 2017-04-06 | Sorrento Therapeutics, Inc. | Antigen binding proteins that bind CXCR5 |
-
2018
- 2018-03-22 JP JP2019552040A patent/JP2020514386A/ja active Pending
- 2018-03-22 IL IL318907A patent/IL318907A/en unknown
- 2018-03-22 KR KR1020197030748A patent/KR20190131068A/ko not_active Ceased
- 2018-03-22 AU AU2018238540A patent/AU2018238540B2/en active Active
- 2018-03-22 EP EP18714200.5A patent/EP3601344A1/en active Pending
- 2018-03-22 KR KR1020257011427A patent/KR20250052493A/ko active Pending
- 2018-03-22 CN CN201880033498.8A patent/CN110662767A/zh active Pending
-
2019
- 2019-09-18 IL IL26941919A patent/IL269419A/en unknown
-
2023
- 2023-01-13 JP JP2023003470A patent/JP2023040241A/ja active Pending
- 2023-08-01 US US18/363,681 patent/US20240207397A1/en active Pending
-
2025
- 2025-02-28 JP JP2025031035A patent/JP2025087764A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025111463A5 (https=) | ||
| JP2025087764A5 (https=) | ||
| JP2021526022A5 (https=) | ||
| JP2008529497A5 (https=) | ||
| US20260035455A1 (en) | ANTI-IL-1ß ANTIBODY AND PHARMACEUTICAL COMPOSITION THEREOF AND USE OF SAME | |
| JP2011502137A5 (https=) | ||
| JP2023093753A5 (https=) | ||
| JP2021500916A5 (https=) | ||
| JP2012532851A5 (https=) | ||
| JP2024024114A5 (https=) | ||
| CN113015745A (zh) | 针对金黄色葡萄球菌白细胞毒素的抗体 | |
| WO2017059813A1 (zh) | 抗乙肝表面抗原的抗体及其用途 | |
| WO2022228183A1 (zh) | 抗siglec15抗体及其制备方法和用途 | |
| JP2026508246A (ja) | 抗体、抗原結合フラグメント及び使用方法 | |
| WO2022179466A1 (zh) | 抗Siglec15抗体及其用途 | |
| JP2023040241A5 (https=) | ||
| CN113444177A (zh) | 抗IL-1β的抗体、其药物组合物及其用途 | |
| CN114578066B (zh) | 检测β-淀粉样蛋白的产品和方法 | |
| CN116178530A (zh) | 抗体在治疗SARS-CoV-2感染的用途 | |
| IL277899B2 (en) | Methods and preparations for treating yellow fever | |
| JPWO2023020621A5 (https=) | ||
| CN114594272A (zh) | 用于检测β-淀粉样蛋白的产品和方法 | |
| WO2025108184A1 (zh) | 抗Tmem176b抗体、药物组合物及用途 | |
| TW202108631A (zh) | 一種抗ｃｄ４７抗原結合蛋白及其應用 | |
| CN114605532B (zh) | 抗β-淀粉样蛋白抗体及其用途 |